Suppr超能文献

球囊测试阻断和血管内母动脉阻断术在颅内复杂动脉瘤性疾病的评估和治疗中的应用。

Balloon test occlusion and endosurgical parent artery sacrifice for the evaluation and management of complex intracranial aneurysmal disease.

机构信息

Texas A&M University Health Science Center College of Medicine, Scott and White Clinic, Temple, Texas, USA.

出版信息

J Neurointerv Surg. 2009 Dec;1(2):112-20. doi: 10.1136/jnis.2009.000539. Epub 2009 Oct 30.

Abstract

The lifetime risk of developing a cerebral aneurysm is about 5%. For some patients, aneurysms can be reasonably managed by conservative measures, including periodic clinical and imaging surveillance. However, the definitive treatment of cerebral aneurysm disease requires securing the aneurysm by surgically excluding it from the cerebrovascular circulation. Most commonly, this can be achieved by either open surgical clipping or embosurgery. Unfortunately, for a minority of patients, these interventions are inadequate because of many aneurysmal factors, such as complex anatomy, giant and wide neck aneurysmal morphology, peripheral small branch origin and skull base location. In situations like these, sacrifice of the parent artery may be preferable, especially when clinical tolerance or image based vascular reserve can be preoperatively demonstrated during temporary occlusion of the vessel. This preoperative procedure, which is known as the Balloon Test Occlusion (BTO), has several variations and technical nuances that can assist the surgeon in predicting which patients may best benefit from parent artery sacrifice (PAS). Together, BTO and PAS are invaluable tools in the management of complicated and atypical cerebral aneurysms. With regard to cerebrovascular aneurysm disease, this review will summarize the development of these procedures, condense the predictability of the numerous BTO variations and provide an overview of the currently available PAS techniques.

摘要

颅内动脉瘤的终身发病风险约为 5%。对于一些患者,可以通过保守措施(包括定期的临床和影像学监测)合理地对动脉瘤进行管理。然而,颅内动脉瘤疾病的确定性治疗需要通过手术将动脉瘤从脑血管循环中隔离出来以确保安全。最常见的方法是通过开颅夹闭或血管内栓塞术来实现。不幸的是,对于少数患者来说,由于许多动脉瘤因素,如复杂的解剖结构、巨大和宽颈动脉瘤形态、周边小分支起源和颅底位置,这些干预措施并不充分。在这种情况下,牺牲载瘤动脉可能是更好的选择,尤其是在术前通过暂时闭塞血管可以显示出临床耐受性或基于影像学的血管储备时。这种术前程序称为球囊闭塞试验(BTO),它有几种变化和技术细节,可以帮助外科医生预测哪些患者最适合接受载瘤动脉牺牲(PAS)。BTO 和 PAS 一起是治疗复杂和非典型颅内动脉瘤的宝贵工具。就脑血管动脉瘤疾病而言,本文将总结这些程序的发展,浓缩众多 BTO 变化的可预测性,并概述目前可用的 PAS 技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验